Diabetes Research Grants

The Diabetes Research Center of the University of Pennsylvania requests submission of applications for support to perform pilot and feasibility studies in diabetes and related endocrine and metabolic disorders.

Young investigators who are starting their laboratories, or established investigators who wish to take a new direction to their studies, are encouraged to submit applications to the Diabetes Research Center, 501 Stemmler Hall, by Friday, December 20, 1996.

An original and 12 copies of the standard NIH forms for ROI grant applications must be used. The recommended format of A) Specific Aims, B) Background & Significance, C) Preliminary Studies, and D) Experimental Design Methods should be used for the Research Plan.

However, since the proposal is intended to obtain additional preliminary data on a topic for a later, more complete grant submission or to test the feasibility of a hypothesis, and is for a one or two year duration only. The overall length of the application must not be more than 10 pages of single -spaced typescript.

If human subjects will be participating in the proposed research, it will be necessary to submit NIH Human Subject forms with the application; if animal research is being proposed, we will need an original and 3 copies of the Institutional Animal Care and Use Committee (IACUC) protocol forms.

Grants will be reviewed by the Diabetes Research Center's Pilot and Feasibility Review Committee and by extramural consultants. Based upon the outstanding evaluation of the recent competitive renewal of the Diabetes Research Center, we anticipate that awards of up to $25,000 will he made (equipment and travel fund requests are not permitted) and will be funded for one year.

Investigators who are currently in the year 1 of support through this Pilot and Feasibility Program may reapply for an additional year of funding. Such continuation requests need to be carefully justified, however, and will be considered as a competing renewal application. Notification of an award will be made in April of 1997. For further information, please contact Dr. Mitchell Lazar, Department of Medicine and Genetics, Room 61lA/6349 (ext. 8-0210).

-- Franz M. Matschinsky, Director, Diabetes and Endocrinology Research Center
-- Mitch Lazar Director, Pilot and Feasibility Grant Program


Volume 43 Number 10
October 29, 1996

Return to Almanac's homepage.

Return to index for this issue.